Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Icomidocholic acid (Aramchol) | 246529-22-6 | 99.98% | 702.10 | 1 ML
SDP

Catalog No. 5000402062
Encompass_Preferred

Icomidocholic acid (Aramchol) is a lipid molecule synthesized from cholic acid and arachidic acid. It is an orally active SCD1 inhibitor and cholesterol solubilizer with antifibrotic effects. Icomidocholic acid can reduce liver fat content, dissolve cholesterol crystals, and prevent gallstone formation, making it suitable for the study of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

  • Orally active SCD1 inhibitor
  • Cholesterol solubilizer
  • Antifibrotic effects
  • Reduces liver fat content
  • Dissolves cholesterol crystals
  • Prevents gallstone formation
  • Suitable for NAFLD and NASH studies

Catalog No. 50-004-02062 Supplier Medchemexpress LLC Supplier No. HY1979610MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Icomidocholic acid (Aramchol) is a lipid molecule synthesized from cholic acid and arachidic acid. It is an orally active SCD1 inhibitor and cholesterol solubilizer with antifibrotic effects. Icomidocholic acid can reduce liver fat content, dissolve cholesterol crystals, and prevent gallstone formation, making it suitable for the study of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

  • Orally active SCD1 inhibitor
  • Cholesterol solubilizer
  • Antifibrotic effects
  • Reduces liver fat content
  • Dissolves cholesterol crystals
  • Prevents gallstone formation
  • Suitable for NAFLD and NASH studies

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.